Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Randomized trial of acute changes in plasma phosphate after phosphorus-standardized meals in peritoneal dialysis

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease

    Publikation: Bidrag til tidsskriftLederpeer review

  3. Impact of CKD on Household Income

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Circadian rhythm of markers of bone turnover in patients with chronic kidney disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. The Arg82Cys polymorphism of the protein Nepmucin implies a role in HDL metabolism

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Administration of whey protein complexed vitamin D3 to vitamin D3-deficient growing Sprague-Dawley rats

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. SGLT2-hæmning til kronisk nyresygdom uden ledsagende diabetes eller hjertesvigt

    Publikation: Bidrag til tidsskriftReviewpeer review

Vis graf over relationer

Introduction: Hyperphosphatemia is associated with increased morbidity and mortality in patients with chronic kidney disease. The aim of this study was to assess whether a meal with high phosphorus content would affect plasma phosphate in the hours that follow among subjects with end-stage kidney disease on peritoneal dialysis.

Methods: This was a single-blinded randomized cross-over trial of 12 subjects on maintenance peritoneal dialysis, in which subjects were randomized to consume a meal with either high or low phosphorus content on 2 separate trial days. On each trial day, plasma phosphate was measured immediately before consumption of the standardized meal and after 1, 2, 3, and 5 hours.

Results: The mean fasting plasma phosphate at baseline was 1.69 ± 0.22 mmol/l. Plasma phosphate was similar between the 2 meals at baseline, as well as at 1, 2, 3, and 5 hours after consumption. The largest observed difference in plasma phosphate between the 2 meals was 0.15 mmol/l, which occurred 5 hours after consumption (high-phosphorus meal 1.75 ± 0.32 mmol/l vs. low-phosphorus meal 1.60 ± 0.14 mmol/l (P = 0.06)). Using summary analyses for repeated measures, we observed a significant difference in the plasma phosphate between the 2 meals (P = 0.03).

Conclusion: Our results show that in subjects with end-stage kidney disease, a meal with high phosphorus content has only a negligible effect on plasma phosphate compared to a meal with low phosphorus content. Thus, large increases in plasma phosphate cannot be accounted for by a high intake of phosphorus in the hours before blood sampling.

OriginalsprogEngelsk
TidsskriftKidney International Reports
Vol/bind6
Udgave nummer2
Sider (fra-til)304-312
Antal sider9
ISSN2468-0249
DOI
StatusUdgivet - feb. 2021

ID: 64231383